AlgaHealth
AlgaHealth: novel cultivation technologies of unique microalgae strains for high quality of fucoxanthin-based products.
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0AlgaHealth project word cloud
Explore the words cloud of the AlgaHealth project. It provides you a very rough idea of what is the project "AlgaHealth" about.
Project "AlgaHealth" data sheet
The following table provides information about the project.
| Coordinator |
ALGAHEALTH (AH) Ltd
Organization address contact info |
| Coordinator Country | Israel [IL] |
| Project website | https://www.alga-health.com/ |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-1 |
| Funding Scheme | SME-1 |
| Starting year | 2019 |
| Duration (year-month-day) | from 2019-07-01 to 2019-11-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | ALGAHEALTH (AH) Ltd | IL (Misgav) | coordinator | 50˙000.00 |
Map
Project objective
Obesity, diabetes and other metabolic syndromes affect an increasing proportion of the population and pose significant economic burden to healthcare systems. To prevent and treat lifestyle-related diseases, it is not sufficient to use an exclusively pharmacological treatment. Nutrition also plays a critical role. Therefore, researchers began to find safe and effective functional ingredients in food to prevent and treat such diseases. One of these functional ingredients is fucoxanthin - a golden-brown carotenoid found in macro and microalgae.
The common method to harvest fucoxanthin is from macroalgae (brown seaweeds), but it is not an acceptable alternative because it is seasonal, not sustainable and allows to the extraction of very low quantities of fucoxanthin. The only alternative for a more efficient and sustainable production of fucoxanthin are microalgae. However, existing production techniques of microalgae require high investment and large energy input, preventing large scale and sustainable production.
At AlgaHealth we isolated, developed and cultivated new and proprietary microalgae strains of Isochrysis species and novel agro-physiological manipulations to make them grow faster and produce more fucoxanthin. These novel technologies constitute a proven and efficient platform for industrial scale production of high quality fucoxanthin-based oleoresin, at lower energy and environmental-friendly production costs.
AlgaHealth is an Israeli biotech company founded in 2017 and stemming from its co-founders’ 20-year experience in microalgae and carotenoids industries. The proposed work in Phase 1 of the SME instrument fits into our overall plan to reach the market by contributing the financial resources needed to plan a fast sound wider deployment of AlgaHealth products and their market uptake.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALGAHEALTH" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ALGAHEALTH" are provided by the European Opendata Portal: CORDIS opendata.